Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel A Freedman

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
Journal of the National Cancer Institute|November 27, 2008
Reducing disparities in breast cancer care: a daunting but essential responsibilityRachel A Freedman, Eric P Winer
Breast (Edinburgh, Scotland)|December 26, 2009
Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancerRachel A Freedman, Eric P Winer
Current Breast Cancer Reports|July 4, 2012
Treatment of Breast Cancer Brain MetastasesRachel A Freedman, Carey K Anders
Clinical Breast Cancer|February 24, 2019
Impact of Subtype on Survival of Young Patients With Stage IV Breast CancerRin Ogiya, Yasuaki Sagara, Naoki Niikura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2021
Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation UpdateSharon H Giordano, Rachel A Freedman, Mark R Somerfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2008
Trends in racial and age disparities in definitive local therapy of early-stage breast cancerRachel A Freedman, Yulei He, Eric P Winer, et al.
Breast (Edinburgh, Scotland)|December 19, 2021
The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysisHee Jeong Kim, Seonok Kim, Rachel A Freedman, et al.
Breast Cancer Research and Treatment|June 25, 2016
Learning from social media: utilizing advanced data extraction techniques to understand barriers to breast cancer treatmentRachel A Freedman, Kasisomayajula Viswanath, Ines Vaz-Luis, et al.
Health Services Research|May 14, 2013
Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care?Rachel A Freedman, Yulei He, Eric P Winer, et al.
American Journal of Clinical Oncology|December 27, 2017
Treatment Patterns Among Women Diagnosed With Stage I-III Triple-negative Breast CancerHelmneh M Sineshaw, Rachel A Freedman, Carol E DeSantis, et al.
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Journal of the National Cancer Institute|November 27, 2008
Reducing disparities in breast cancer care: a daunting but essential responsibilityRachel A Freedman, Eric P Winer
Breast (Edinburgh, Scotland)|December 26, 2009
Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancerRachel A Freedman, Eric P Winer
Current Breast Cancer Reports|July 4, 2012
Treatment of Breast Cancer Brain MetastasesRachel A Freedman, Carey K Anders
Clinical Breast Cancer|February 24, 2019
Impact of Subtype on Survival of Young Patients With Stage IV Breast CancerRin Ogiya, Yasuaki Sagara, Naoki Niikura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2021
Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation UpdateSharon H Giordano, Rachel A Freedman, Mark R Somerfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2008
Trends in racial and age disparities in definitive local therapy of early-stage breast cancerRachel A Freedman, Yulei He, Eric P Winer, et al.
Breast (Edinburgh, Scotland)|December 19, 2021
The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysisHee Jeong Kim, Seonok Kim, Rachel A Freedman, et al.
Breast Cancer Research and Treatment|June 25, 2016
Learning from social media: utilizing advanced data extraction techniques to understand barriers to breast cancer treatmentRachel A Freedman, Kasisomayajula Viswanath, Ines Vaz-Luis, et al.
Health Services Research|May 14, 2013
Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care?Rachel A Freedman, Yulei He, Eric P Winer, et al.
American Journal of Clinical Oncology|December 27, 2017
Treatment Patterns Among Women Diagnosed With Stage I-III Triple-negative Breast CancerHelmneh M Sineshaw, Rachel A Freedman, Carol E DeSantis, et al.
Pageof 17